The International Diabetes Federation (IDF) announced the launch of a new global effort to quantify the regional and global burden of cardiovascular disease (CVD) in people with diabetes.
CVD is one of the most common complications associated with diabetes and is responsible for over one third of all deaths in people with diabetes. This project is supported by a grant from the AstraZeneca/Bristol Myers Squibb Diabetes Alliance.
Through this multi-pronged effort, IDF will work toward the publication of an update to the 2001 publication Time to Act: Diabetes & Cardiovascular Disease in collaboration with a global panel of experts assembled by IDF. The updated publication will:
- Raise public awareness about the links between diabetes and CVD
- Update the evidence base for CVD and diabetes
- Enable global and national policy makers to make informed decisions on diabetes
- Influence policy and discussion around diabetes in the post-2015 development agenda
The project will be carried out in three phases over the course of two years:
- A scientific literature review on CVD in people with diabetes
- Establishment of a model for estimating the burden of CVD in people with diabetes
- Generation of global and regional estimates of the burden of CVD in people with diabetes
IDF will ensure that the project produces the data needed to mobilize and strengthen the global diabetes community and to drive the fight against diabetes on all levels of society worldwide.